期刊文献+

氟烷、安氟醚、七氟醚肝毒性与TXB_2、6-keto-PGF(1α)含量变化(氟烷性肝炎的研究Ⅲ) 被引量:1

Hepatotoxicity of Halothane,Enflurane and Sevoflurane and Change of TXB_2 and 6-keto-PGF1a
下载PDF
导出
摘要 雄性SD大鼠饮用含苯巴比妥钠(1mg/ml)的饮水1周后,随机分为四组,每组8例,分别吸入:C,14%O_2/86%N_2;E,14%O_2/86%N_2/1.2MAC安氟醚;S,14%O_2/86%N_2/1.2MAC七氟醚;H,14%O_2/86%N_2/1.2MAC氟烷1h。24h后发现H组血浆ALT活性显著高于其它各组,并有明显的小叶中心性肝细胞坏死及汇管区炎细胞浸润,血窦重度充血。E组可见部分肝小叶内有小叶中心性坏死及空泡变性。H组肝匀浆及血浆中TXB_2含量显著高于其它各组。6-keto-PGF1a各组间均无显著差异。提示氟烷性肝炎与TXA_2/PGI_2平衡失调有一定的关系。 Male Sprague-Dawley rats were pretreated with phenobarbital and randomly divided into 4 groups, The ratswere exposed to O2/N2/1.2 MAC anesthetics for 1 hr and anesthetized by 14%O2/86%N2/(C), 14%O2/86%N2/1. 2MAC enflurane(E),14%O2/86%N2/1. 2MAC sevoflurane(S)and 14%O2/86%/N2/1. 2 MAC halothane(H)respectively. The livers of all rats given halothane had extensive centrilobular necrosis and denaturation. Accom-panying the morphologic damage was an increase in serum glutamic pyruvic transminase(ALT).The concentra-tions of TXB2 in plasma and the liver were significantly raised in group H(P< 0.01).With regard to 6-keto-PGF1a, no statistically significant difference was found in all groups.It is concluded that an imbalance of TXA2/PGI2 may be partly responsible for halothane hepatitis.
出处 《临床麻醉学杂志》 CAS CSCD 北大核心 1994年第2期61-64,共4页 Journal of Clinical Anesthesiology
关键词 麻醉药 肝毒性 血栓素B2 前列腺素 Volatile anesthetics Hepatotoxicity TXB2 6-keto-PGF1a
  • 相关文献

参考文献3

共引文献10

同被引文献25

  • 1俞卫锋,刘树孝,王景阳,于布为.氟烷七氟醚对酶诱导缺氧大鼠脂过氧化反应的影响(氟烷性肝炎的研究Ⅰ)[J].临床麻醉学杂志,1994,10(1):7-9. 被引量:2
  • 2俞卫锋,于布为,王景阳,刘树孝.大鼠氟烷性肝炎血、肝中微量元素的测定及其临床意义─—与七氟醚麻醉比较(氟烷性肝炎的研究Ⅳ)[J].临床麻醉学杂志,1994,10(2):64-66. 被引量:1
  • 3俞卫锋,王景阳,刘树孝,于布为.氟烷、七氟醚对离体大鼠肝细胞钙平衡的影响[J].中华麻醉学杂志,1994,14(3):169-171. 被引量:2
  • 4Turillazzi E, D'Errico S, Neri M, et al. A fatal case of fuhninant hepatic necrosis following sevoflurane anesthesia. Toxieol Pathol, 2007, 35(6) : 780-785.
  • 5Gonzalo Pascual V, Forner Gonzolez A, Salvador E, et al. Severe acute hepatitis after anesthesia with sevoflurane. Gastroenterol Hepatol, 2005, 28(6): 361-362.
  • 6Lehmann A, Neher M, Kiessling AH. Case report: fatal hepatic failure after aortic valve replacement and sevoflurane exposure. Can J Anaesth, 2007, 54( 11 ): 917-921.
  • 7Ebert TJ, Messana LD, Uhrich TD, et al. Absence of renal and hepatic toxicity after four hour of 1.25 minimum alveolar anesthetic concentration sevoflurane anesthesia in volunteers. Anesth Analg, 1998, 86 (3) : 662-667.
  • 8Ebert TJ, Frink EJ Jr, Kharasch ED. Absence of biochemical evi - dence for renal and hepatic dysfunction after 8hours of 1.25 minimum alveolar comcentration sevoflurane anesthesia in volunteers, Anesthesiology, 1998, 88(3): 601-610.
  • 9Nishiyama T, Yokoyama T, Hanaoka K. Liver function after sevoflurane or isoflurane anaesthesia in neurosurgieal patients. Can J Anaesth, 1998, 45(8): 753-756.
  • 10Nishiyama T, Fujimoto T, Hanaoka K. A comparison of liver function after hepatectomy in cirrhotic patients between sevoflurane and isoflurane in anesthesia with nitrous oxide and epidural block. Anesth Analg, 2004, 98(4): 990-993.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部